<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05047419</url>
  </required_header>
  <id_info>
    <org_study_id>202104290</org_study_id>
    <nct_id>NCT05047419</nct_id>
  </id_info>
  <brief_title>Asthma in Pregnancy</brief_title>
  <official_title>Using Mobile Health Approaches to Improve Asthma Treatment</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Linnea Polgreen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Iowa</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The long-term goal is to improve the care of patients with asthma. The overarching objective&#xD;
      of this pilot grant is to test the feasibility, acceptability and potential clinical utility&#xD;
      of deploying a mobile-health intervention to improve asthma surveillance.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Asthma is a major cause of morbidity. Asthma is frequently underdiagnosed, and proven&#xD;
      therapies are underused. Even among patients treated for asthma, adherence to treatment is&#xD;
      often is suboptimal.&#xD;
&#xD;
      Adherence to asthma therapy depends not only on regular use of therapies, but also correct&#xD;
      technique for inhaler use. To improve treatments, home-based interventions have been&#xD;
      proposed. Many such solutions involve collecting patient data to motivate patients and alert&#xD;
      providers to ongoing problems. Examples of proposed solutions include using an app to keep&#xD;
      symptom and medication logs, using Fitbits to document physical limitations, and nighttime&#xD;
      breathing sensors. Other proposals include using peak expiratory flow meters, portable&#xD;
      spirometers, and portable oscillometry. While promising, most of these efforts have, to date,&#xD;
      not expanded widely beyond research settings.&#xD;
&#xD;
      Asthma during pregnancy is especially important to treat. Uncontrolled asthma is associated&#xD;
      with preeclampsia, low birth weight, and fetal death. For some patients asthma is less severe&#xD;
      during pregnancy, but for others, asthma worsens. In addition, pregnant patients with asthma&#xD;
      often decrease use of medication or stop therapy altogether. Many pregnant patients stop&#xD;
      therapy due to worry about negative effects on the baby. In general, asthma therapy is safe&#xD;
      for pregnant patients and the babies, and hypoxia is dangerous for both.&#xD;
&#xD;
      Despite the importance of asthma treatment during pregnancy, some healthcare providers do not&#xD;
      encourage pregnant patients with asthma to continue with asthma treatment. Many providers do&#xD;
      not feel qualified to educate and treat patients during pregnancy, and pregnant patients may&#xD;
      not be adequately informed that asthma therapy is safe. Also, pregnant patients may minimize&#xD;
      their symptoms if worried about the safety of therapies. Accordingly, collecting objective&#xD;
      information from patients in the home environment could improve the health of pregnant&#xD;
      patients and the babies. Home monitoring may be especially important for patients living in&#xD;
      rural areas with limited access to healthcare.&#xD;
&#xD;
      Home measurements of asthma symptoms can supplement clinic visits. However, this approach&#xD;
      requires disciplined follow-up on the part of both patients and the healthcare team. Patients&#xD;
      are required to use peak flow meters and regularly share results with providers. In addition,&#xD;
      healthcare providers need to act on the shared data.&#xD;
&#xD;
      The purpose of this study is to determine if patients with asthma (pregnant and not pregnant)&#xD;
      will take daily measurements with a peak flow meter and return them to the research team.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 27, 2021</start_date>
  <completion_date type="Anticipated">December 2022</completion_date>
  <primary_completion_date type="Anticipated">December 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Comparison of Number of Peak Flow Measurements Received</measure>
    <time_frame>9 months</time_frame>
    <description>Comparison of number of peak flow measurements received between pregnant and not pregnant groups.</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Asthma</condition>
  <condition>Pregnancy</condition>
  <arm_group>
    <arm_group_label>Pregnant Participants with Asthma</arm_group_label>
    <description>Participants will be asked to use peak flow meter each day from enrollment to 6 weeks post due date and send peak flow and FEV1 values to the research team via text message. Also, every 3 months participants will be asked to send in a PDF of the values from the peak flow meter app for the previous 7 days via email as a validation of the text message values.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Not Pregnant Participants with Asthma</arm_group_label>
    <description>Participants will be asked to use peak flow meter each day from enrollment to 9 months and send peak flow and FEV1 values to the research team via text message. Also, every 3 months participants will be asked to send in a PDF of the values from the peak flow meter app for the previous 7 days via email as a validation of the text message values.</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Pregnant and Not Pregnant participants with an Asthma diagnosis.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Able to read and write in English or Spanish;&#xD;
&#xD;
          -  Current patient at participating clinic;&#xD;
&#xD;
          -  Diagnosis of asthma;&#xD;
&#xD;
          -  Owns a smartphone capable of supporting Bluetooth-enabled peak flow meter.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  3rd trimester of pregnancy;&#xD;
&#xD;
          -  Current prisoner status;&#xD;
&#xD;
          -  Unable to provide own written informed consent.&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Linnea Polgreen, PHD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Iowa</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Linnea Polgreen, PHD</last_name>
    <phone>384-3024</phone>
    <email>linnea-polgreen@uiowa.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Shelby Francis, PHD</last_name>
    <phone>319-678-8037</phone>
    <email>shelby-francis@uiowa.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of Iowa Hospitals &amp; Clinics</name>
      <address>
        <city>Iowa City</city>
        <state>Iowa</state>
        <zip>52242</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shelby L Francis, PhD</last_name>
      <phone>319-775-0689</phone>
      <email>shelby-francis@uiowa.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Loftus PA, Wise SK. Epidemiology of asthma. Curr Opin Otolaryngol Head Neck Surg. 2016 Jun;24(3):245-9. doi: 10.1097/MOO.0000000000000262. Review.</citation>
    <PMID>26977741</PMID>
  </reference>
  <reference>
    <citation>Cloutier MM. Asthma management programs for primary care providers: increasing adherence to asthma guidelines. Curr Opin Allergy Clin Immunol. 2016 Apr;16(2):142-7. doi: 10.1097/ACI.0000000000000242. Review.</citation>
    <PMID>26849166</PMID>
  </reference>
  <reference>
    <citation>Morton RW, Elphick HE, Craven V, Shields MD, Kennedy L. Aerosol Therapy in Asthma-Why We Are Failing Our Patients and How We Can Do Better. Front Pediatr. 2020 Jun 11;8:305. doi: 10.3389/fped.2020.00305. eCollection 2020. Review.</citation>
    <PMID>32656165</PMID>
  </reference>
  <reference>
    <citation>Moran C, Doyle F, Sulaiman I, Bennett K, Greene G, Molloy GJ, Reilly RB, Costello RW, Mellon L. The INCA(TM) (Inhaler Compliance Assessment(TM)): A comparison with established measures of adherence. Psychol Health. 2017 Oct;32(10):1266-1287. doi: 10.1080/08870446.2017.1290243. Epub 2017 Feb 28. Erratum in: Psychol Health. 2017 Oct;32(10):i.</citation>
    <PMID>28276739</PMID>
  </reference>
  <reference>
    <citation>Greiwe J, Nyenhuis SM. Wearable Technology and How This Can Be Implemented into Clinical Practice. Curr Allergy Asthma Rep. 2020 Jun 6;20(8):36. doi: 10.1007/s11882-020-00927-3. Review.</citation>
    <PMID>32506184</PMID>
  </reference>
  <reference>
    <citation>Kouri A, Gupta S, Yadollahi A, Ryan CM, Gershon AS, To T, Tarlo SM, Goldstein RS, Chapman KR, Chow CW. Addressing Reduced Laboratory-Based Pulmonary Function Testing During a Pandemic. Chest. 2020 Dec;158(6):2502-2510. doi: 10.1016/j.chest.2020.06.065. Epub 2020 Jul 8. Review.</citation>
    <PMID>32652095</PMID>
  </reference>
  <reference>
    <citation>Bousquet J, Arnavielhe S, Bedbrook A, Bewick M, Laune D, Mathieu-Dupas E, Murray R, Onorato GL, Pépin JL, Picard R, Portejoie F, Costa E, Fonseca J, Lourenço O, Morais-Almeida M, Todo-Bom A, Cruz AA, da Silva J, Serpa FS, Illario M, Menditto E, Cecchi L, Monti R, Napoli L, Ventura MT, De Feo G, Larenas-Linnemann D, Fuentes Perez M, Huerta Villabolos YR, Rivero-Yeverino D, Rodriguez-Zagal E, Amat F, Annesi-Maesano I, Bosse I, Demoly P, Devillier P, Fontaine JF, Just J, Kuna TP, Samolinski B, Valiulis A, Emuzyte R, Kvedariene V, Ryan D, Sheikh A, Schmidt-Grendelmeier P, Klimek L, Pfaar O, Bergmann KC, Mösges R, Zuberbier T, Roller-Wirnsberger RE, Tomazic P, Fokkens WJ, Chavannes NH, Reitsma S, Anto JM, Cardona V, Dedeu T, Mullol J, Haahtela T, Salimäki J, Toppila-Salmi S, Valovirta E, Gemicioğlu B, Yorgancioglu A, Papadopoulos N, Prokopakis EP, Bosnic-Anticevich S, O'Hehir R, Ivancevich JC, Neffen H, Zernotti E, Kull I, Melen E, Wickman M, Bachert C, Hellings P, Palkonen S, Bindslev-Jensen C, Eller E, Waserman S, Sova M, De Vries G, van Eerd M, Agache I, Casale T, Dykewickz M, Naclerio RN, Okamoto Y, Wallace DV; MASK study group. MASK 2017: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma multimorbidity using real-world-evidence. Clin Transl Allergy. 2018 Oct 25;8:45. doi: 10.1186/s13601-018-0227-6. eCollection 2018. Review. Erratum in: Clin Transl Allergy. 2019 Oct 9;9:51.</citation>
    <PMID>30386555</PMID>
  </reference>
  <reference>
    <citation>Huffaker MF, Carchia M, Harris BU, Kethman WC, Murphy TE, Sakarovitch CCD, Qin F, Cornfield DN. Passive Nocturnal Physiologic Monitoring Enables Early Detection of Exacerbations in Children with Asthma. A Proof-of-Concept Study. Am J Respir Crit Care Med. 2018 Aug 1;198(3):320-328. doi: 10.1164/rccm.201712-2606OC.</citation>
    <PMID>29688023</PMID>
  </reference>
  <reference>
    <citation>McLaughlin K, Foureur M, Jensen ME, Murphy VE. Review and appraisal of guidelines for the management of asthma during pregnancy. Women Birth. 2018 Dec;31(6):e349-e357. doi: 10.1016/j.wombi.2018.01.008. Epub 2018 Feb 21. Review.</citation>
    <PMID>29475603</PMID>
  </reference>
  <reference>
    <citation>Bonham CA, Patterson KC, Strek ME. Asthma Outcomes and Management During Pregnancy. Chest. 2018 Feb;153(2):515-527. doi: 10.1016/j.chest.2017.08.029. Epub 2017 Sep 1. Review.</citation>
    <PMID>28867295</PMID>
  </reference>
  <reference>
    <citation>Robijn AL, Murphy VE, Gibson PG. Recent developments in asthma in pregnancy. Curr Opin Pulm Med. 2019 Jan;25(1):11-17. doi: 10.1097/MCP.0000000000000538. Review.</citation>
    <PMID>30407268</PMID>
  </reference>
  <reference>
    <citation>Labor S, Dalbello Tir AM, Plavec D, Juric I, Roglic M, Pavkov Vukelic J, Labor M. What is safe enough - asthma in pregnancy - a review of current literature and recommendations. Asthma Res Pract. 2018 Dec 27;4:11. doi: 10.1186/s40733-018-0046-5. eCollection 2018. Review.</citation>
    <PMID>30607253</PMID>
  </reference>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>September 8, 2021</study_first_submitted>
  <study_first_submitted_qc>September 16, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">September 17, 2021</study_first_posted>
  <last_update_submitted>September 27, 2021</last_update_submitted>
  <last_update_submitted_qc>September 27, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 5, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>University of Iowa</investigator_affiliation>
    <investigator_full_name>Linnea Polgreen</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Asthma</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

